UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 10, 2014

Accession Number:	0001387131-14-002330
Submission Type:	POS AM
CIK: 0000887247 Company Name: Adamis Pharmaceuticals Corp File Number: 333-190798